Savings options for Zepbound - Eli Lilly and Company
Learn more about the Zepbound® savings card (no Gov`t beneficiaries, terms apply), the Zepbound cash option, and LillyDirect™, an online pharmacy solutions option.
How do I get Zepbound® (tirzepatide) vials? - medical.lilly.com
Eli Lilly and Company has created a new self-pay pharmacy component of LillyDirect® where patients with a valid, on-label, electronic prescription from the health care provider of their choice can purchase Zepbound 2.5 and 5 mg vials.1
Zepbound®(tirzepatide) - Eli Lilly and Company
to treat moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity. Zepbound contains tirzepatide. Coadministration with other tirzepatide-containing products or with any glucagon-like peptide-1 (GLP-1) receptor agonist is not recommended. Want to learn more about Zepbound? Only the 2.5 mg and 5 mg doses are available in vials.
Mounjaro® (tirzepatide) injection and Zepbound™️ (tirzepatide ...
Zepbound is an injectable prescription medicine that may help adults with obesity, or some adults with overweight who also have weight-related medical problems, to lose excess body weight and keep the weight off. Zepbound should be used with a reduced- …
Resources, Support, Tips & Guides | Zepbound® (tirzepatide)
Text "ZB" to 85099 to access your kit and learn about starting on Zepbound. 2.5 mg is the starting dose and not intended for chronic weight management. Get the details in our videos below, and please read the full Instructions for Use included with your Zepbound pen or Zepbound vial.
Zepbound® (tirzepatide) | Eli Lilly and Company
Zepbound (tirzepatide) is an injectable prescription medicine that may help adults with obesity, or with excess weight (overweight) who also have weight-related medical problems, lose weight and keep it off.
Zepbound ® (tirzepatide) injection - Eli Lilly and Company
Zepbound is a once-weekly injectable prescription medicine for chronic weight management in adults with an initial body mass index of at least 30 kg/m2 or at least 27 kg/m2 with at least one weight-related comorbid condition.
• Use ZEPBOUND exactly as your healthcare provider tells you to. A healthcare provider should show you how to prepare to inject your dose of ZEPBOUND before injecting the first time. • Use ZEPBOUND with a reduced-calorie diet and increased physical activity.
Lilly releases Zepbound® (tirzepatide) single ... - Eli Lilly and …
INDIANAPOLIS, Aug. 27, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced Zepbound ® (tirzepatide) 2.5 mg and 5 mg single-dose vials are available for self-pay for patients with an on-label prescription, significantly expanding the supply of Zepbound in response to high demand.
FDA approves Zepbound® (tirzepatide) as the first and only …
INDIANAPOLIS, Dec. 20, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) approved Zepbound ® (tirzepatide) as the first and only prescription medicine for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity. 1 Zepbound may help adults with moderate-to-severe ...
- Some results have been removed